Study	Reason for exclusion
OTHER Armah 2013	RCT of withdrawn RV vaccine RRV‐TV
OTHER Bines 2015	Neonatal RV vaccine RV3‐BB in development
OTHER Bines 2018	RCT of unlicensed neonatal RV3‐BB rotavirus vaccine (ACTRN12612001282875)
OTHER Bucardo 2018	Prospective cohort study
OTHER Bucher 2012	Diagnostic test accuracy study
OTHER Chatterjee 2012	RCT, not rotavirus vaccine
OTHER Cowley 2017	RCT of unlicensed neonatal RV3‐BB rotavirus vaccine
OTHER CTRI/2009/091/000821	RCT of Rotasiil versus placebo
OTHER Dang 2012	RCT evaluating safety and immunogenicity of vaccine licensed in Vietnam (NCT01377571); vaccine not prequalified by the WHO
OTHER de Palma 2010	Case‐control study
OTHER Dickson 2017	Brief narrative report
OTHER Diness 2010	Study of vitamin A supplementation with Bacille Calmette‐Guerin vaccine for rotavirus diarrhoea outcomes
OTHER Dutta 2011	RCT, not rotavirus vaccine
OTHER Ella 2018	All infants received rotavirus vaccine, and were randomized to Rotavac (116E) with or without buffering agent. (CTRI/2014/04/004548)
OTHER Friedrich 2017	Editorial on Rotasiil rotavirus vaccine
OTHER Gagneur 2011	Observational study (IVANHOE)
OTHER Groome 2017	RCT in infants of RV vaccine in development: parenteral P2‐VP8‐P[8] subunit RV vaccine (NCT02109484)
OTHER Hiramatsu 2018	Prospective cohort study
OTHER Isanaka 2017‐NER	Reporting on an RCT (NCT02145000) that evaluates safety and efficacy in a vaccine licensed in India but not prequalified by the WHO
OTHER Kempe 2007	Survey of paediatricians about rotavirus disease and rotavirus vaccines
OTHER Kulkarni 2017	Reporting on an RCT (NCT02133690) that evaluates safety and efficacy in a vaccine licensed in India but not prequalified by the WHO
OTHER Muhsen 2010	Case‐control study
OTHER NCT00981669	RCT included adults aged 18 ‐ 40 years
OTHER NCT01195844	Observational study, prematurely terminated for poor recruitment
OTHER NCT01236066	Ongoing observational study
OTHER NCT01375907	Ongoing study with adult participants
OTHER NCT01571505	RCT in infants comparing RV vaccine administered with IPV or OPV
OTHER Rivera 2011	RCT, no placebo comparison
OTHER Thyagarajan 2011	Procedural codes for rotavirus vaccination in the USA
OTHER Yin 2017	Oral RV vaccine (not specified, could be both RV1 and RV5) was administered before versus after other injected vaccines to compare injection site pain of the other vaccines
OTHER Zade 2014a‐IND	Reporting on an RCT that evaluates safety in a vaccine licensed in India but not prequalified by the WHO
OTHER Zade 2014b‐IND	Reporting on an RCT (CTRI/2010/091/003064) that evaluates safety in a vaccine licensed in India but not prequalified by the WHO
RV1 / RV5 Libster	RCT of RV1 and RV5 combined in different sequences
RV1 Ali 2014	Comparing different age schedules of RV1
RV1 Armah 2016	Comparing alternative dosing schedules
RV1 Buyse 2014	Integrated analysis
RV1 Correia 2010	Case‐control study
RV1 CTRI/2012/02/002454	Ongoing RCT with no placebo group
RV1 Dennehy 2008	RCT of RV1 vaccine, but no placebo group reported
RV1 Emperador 2016	No placebo group: RV1 on a staggered versus concomitant schedule with other vaccines
RV1 GSK[107077‐057] 2008	RCT of RV1 vaccine, but no placebo group reported
RV1 GSK[107876‐061] 2008	RCT of RV1 vaccine, but no placebo group reported
RV1 GSK[444563‐020] 2007	RCT, but excluded because report mentioned that "4 groups received an investigational vaccination regimen", but no details are provided about this vaccine (may be related to GlaxoSmithKline's RV1 vaccine)
RV1 Herrera 2013	Not an RCT
RV1 Kazi 2017	1 arm of an RCT (RV1 Ali 2014) was included in this sub‐study analysing histo‐blood group antigens
RV1 Kompithra 2014	No placebo group: immunogenicity for 3 versus 5 doses RV1
RV1 Lazarus 2017	All received RV vaccine with or without zinc and/or probiotic supplements
RV1 Lu 2013	Not an RCT
RV1 NCT00353366	Ongoing non‐randomized study
RV1 NCT00382772 2008	RCT comparing RV1 liquid formulation to lyophilized formulation, no placebo
RV1 NCT00653198	Ongoing case‐control study
RV1 NCT00655187	Ongoing case‐control study
RV1 NCT01162590	Ongoing study with adult participants
RV1 NCT01177826	Ongoing observational study
RV1 NCT01273077	Ongoing observational study
RV1 NCT01339221	Ongoing observational study
RV1 Plosker 2011	Economic analysis
RV1 Ramani 2016	No placebo group: RV1 co‐administered with IPV or with OPV was compared.
RV1 Rojas 2007	Viral conversion on the same population of RV1 Ruiz‐Palac 06‐LA/EU (included trial)
RV1 Rongsen‐Chandola 2014	Infants were breastfed versus not breastfed 30 mins prior and post RV1 administration. No placebo group.
RV1 Suryakiran 2011	Not RCT, integrated safety summary
RV1 Taddio 2015	To assess pain at injection site of other vaccines, participants were randomised to 1. oral RV1 then other injected vaccines then oral sucrose, or to 2. oral sucrose then other injected vaccines then oral RV1
RV1 Zaman 2016	Study investigated co‐administration of Measles‐rubella vaccines with RV vaccine
RV5 / BRV‐TV Saluja 2017	RCT of BRV‐TV versus RV5
RV5 ACTRN12611000559910	Ongoing observational study
RV5 Ciarlet 2008	RCT of RV5 vaccine, but no placebo group reported
RV5 El Khoury 2011	Mathematical model in Brazil
RV5 El Khoury 2011a	Mathematical model in six Asian countries
RV5 Martinon‐Torres 2017	RCT comparing standard versus alternative formulation of RV5
RV5 McGrath 2014	Not an RCT
RV5 NCT00130832 2010	Not RCT; open‐label study investigating different schedules of rotavirus and polio vaccine combinations without placebo
RV5 NCT00496054	Ongoing non‐randomized study
RV5 NCT01926015	Staggered versus concomitant administration of DTP‐IPV with RV5
RV5 Saleh 2018	Standard versus alternative schedule RV5 (NCT01960725)
RV5 Tugcu 2009	RCT of RV5 vaccine, no placebo group reported
RV5 Uprety 2017	Sub‐study of RV5 Levin 2017‐AF, this sub‐study only included participants in the vaccine arm and comparied HIV‐positive to HIV‐exposed but uninfected infants.
RV5 Vesikari 2011	RCT of RV5 and MenCC vaccines ‐ concomitant or sequential administration, no placebo group reported
RV5 Weinberg 2017	Sub‐study of selected participants from RV5 Levin 2017‐AF, reporting only irrelevant outcomes for this review.